HealthTech Lead Investors Bootcamp
Join us for a high-impact investor bootcamp designed to help you navigate the complexities of digital health and life science deals.
This in-person event brings together experienced VCs, syndicate leads, and corporate venture decision-makers to dive deep into topics crucial for investors' understanding. Throughout the afternoon, participants will learn how to evaluate market potential, assess teams, and structure smarter deals.
Participants will not only explore these topics in theory, but also have the opportunity to listen to pitch sessions from six promising startups, participate in moderated experience sharing and Q&A with fellow attendees, and gain real insights from active investors: Pekka Simula (Partner at Innovestor Life Science), Ekaterina Gianelli (Venture Partner at Calm/Storm Ventures), and Matti Hautsalo (Founding Partner at Nordic Science Investments)
🗓 Agenda
11:30-12:00 – Welcome coffee ☕
12:00-12:30 – Welcome by the host & participant intro round
12:30-13:15 – Good Opportunity: Market Potential & Market Fit
13:15-14:00 – Good Team: Due Diligence Focus
14:00-14:15 – Coffee break ☕
14:15-15:00 – Good Transaction: Deal Structure & Logic
15:00-16:00 – Startup Pitching Sessions (Digital & Life Sciences)
The event is in English and on-site.
We look forward to seeing you at the HealthTech Lead Investors Bootcamp on May 20! Apply now as seats are limited to 15 investors to ensure depth, interaction, and quality networking.
This event is organised by Civitta and Health Founders Estonia, funded by the European Union through Enterprise Estonia.
***
About the speakers:
Pekka Simula is the Managing Partner of Innovestor Life Science, a €90 million venture capital fund investing in health and life science startups in the New Nordics. Previously a startup founder and operator, Pekka serves as Chairperson or Board Member at several health tech and life science companies, including HVR Cardio, Soihtu DTx, Kasvu Therapeutics, and Gesynta Pharma.
Ekaterina Gianelli is a Venture Partner at Calm/Storm Ventures, Europe’s most active early-stage digital health investor. Based in Helsinki, she has been investing across the region for over a decade, focusing on the earliest stages. Ekaterina previously spent ten years in venture capital as a General Partner at Inventure, a leading seed investor in the Nordics, where she led investments across digital health, enterprise software, and conscious consumption. She also established and led Inventure’s First Cheque programme, targeting angel and pre-seed rounds. Before her tenure at Inventure, Ekaterina was part of the team that scaled Fjord, a prominent design and innovation firm later acquired by Accenture Interactive.
Matti Hautsalo is a Partner and one of the founders of Nordic Science Investments (NSI). Since 2006, he has worked with early-stage technology companies through venture capital and a private investment company, focusing on research-based spinouts in North America, the UK, and Finland. Much of his work has involved a hands-on board member, linking startups with Nordic R&D teams and their international management and shareholder networks. Matti’s earlier investments and directorships related to health care and Life sciences include whole body MRI (Prenuvo), cancer immunotherapy (Valo Therapeutics), quantum chemistry (Algorithmiq), live cell analysis (CM Technologies), and health care ERP (Commit). With the NSI team, Matti has been building an early-stage portfolio with 10 life sciences and health tech investments in Finland and Sweden, following the Estonian early-stage deal flow, too.